Table 3.
Variables | Group/follow-up | B-coeff | Exp (B) | 95% CI | p value | |||||||
Lower | Upper | |||||||||||
%FMD | ||||||||||||
Group | NRT over EC nicotine-containing | 0.46 | 1.61 | − 0.59 | 1.54 | 0.38 | ||||||
EC nicotine-free over EC nicotine-containing | − 0.57 | 0.57 | − 1.74 | 0.60 | 0.34 | |||||||
Follow-up | 3 m over baseline | 2.40 | 20.04 | 1.66 | 3.14 | < 0.0001 | ||||||
6 m over baseline | 2.99 | 11.04 | 2.22 | 3.77 | < 0.0001 | |||||||
Gender | Male over female | − 1.35 | 0.26 | − 2.27 | − 0.43 | 0.004 | ||||||
Age | − 0.02 | 0.98 | − 0.05 | 0.01 | 0.27 | |||||||
Intercept | 7.67 | 5.92 | 9.42 | < 0.0001 | ||||||||
%FMD changes over baseline | NRT | EC—nicotine-containing | EC – nicotine-free | |||||||||
Mean difference | 95% CI | p value | Mean difference | 95% CI | p value | Mean difference | 95% CI | p value | ||||
Lower | Upper | Lower | Upper | Lower | Upper | |||||||
3 months over baseline | ||||||||||||
Cessation subgroup | 2.61 | 0.97 | 4.25 | 0.003 | 3.94 | 1.73 | 6.15 | 0.001 | 4.78 | 2.27 | 7.29 | 0.001 |
6 months over baseline | ||||||||||||
Cessation subgroup | 4.40 | 2.18 | 6.66 | 0.001 | 2.96 | 1.17 | 4.74 | 0.002 | 2.97 | 0.90 | 5.04 | 0.006 |
%FMD, percentage change in flow-mediated dilation